Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of E7386 and Lenvatinib for Patients with Liver, Colon, Endometrial, or Other Solid Tumors

    Recruiting

    1 1 1 1
    Denmark France Italy Spain
  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    France Italy Poland Spain
  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated Drugs:
    France Germany Italy Spain
  • Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

    Recruiting

    2 1 1 1
    Spain Sweden
  • Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Italy The Netherlands
  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Spain
  • Study on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma

    Recruiting

    2 1 1 1
    France Italy Spain
  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    Denmark The Netherlands Spain Sweden
  • Study Comparing Chemotherapy Alone to Dostarlimab, Paclitaxel, and Carboplatin for Patients with Advanced or Metastatic Endometrial Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France Italy Romania Spain